When the Slide Knows the Sequence: Artificial Intelligence-Assisted Pathology Predicts Mutations in Thyroid Cancer

Abstract

Get full access to this article

View all access options for this article.

References

Baloch

, Asa

, Barletta

, et al. Overview of the 2022 WHO Classification of Thyroid Neoplasms. Endocr Pathol, 2022; 33(1):27–63; doi: 10.1007/s12022-022-09707-3

Juhlin

, Mete

, Baloch

. The 2022 WHO classification of thyroid tumors: Novel concepts in nomenclature and grading. Endocr Relat Cancer, 2023; 30(2):e220293; doi: 10.1530/ERC-22-0293

Chu

Y-H

, Sadow

. Kinase Fusion-Related Thyroid Carcinomas: Towards Predictive Models for Advanced Actionable Diagnostics. Endocr Pathol, 2022; 33(4):421–435; doi: 10.1007/s12022-022-09739-9

Mete

, Boucher

, Schrader

, et al. Consensus Statement: Recommendations on Actionable Biomarker Testing for Thyroid Cancer Management. Endocr Pathol, 2024; 35(4):293–308; doi: 10.1007/s12022-024-09836-x

Marion

, Schulz

, Glasner

, et al. Deep learning discovers new morphological features while predicting genetic alterations from histopathology of papillary thyroid carcinoma. Thyroid, 2025; 35(7):771–780; doi: 10.1089/thy.2024.0691

Cancer Genome Atlas Research Network. Integrated genomic characterization of papillary thyroid carcinoma. Cell, 2014; 159(3):676–690; doi: 10.1016/j.cell.2014.09.050